Ergomed PLC
LSE:ERGO
Ergomed PLC
Cost of Revenue
Ergomed PLC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ergomed PLC
LSE:ERGO
|
Cost of Revenue
-£90.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cost of Revenue
-£79.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Cost of Revenue
-£2.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
C4X Discovery Holdings PLC
LSE:C4XD
|
Cost of Revenue
-£16k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Ergomed PLC's Cost of Revenue?
Cost of Revenue
-90.2m
GBP
Based on the financial report for Jun 30, 2023, Ergomed PLC's Cost of Revenue amounts to -90.2m GBP.
What is Ergomed PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-23%
Over the last year, the Cost of Revenue growth was -15%. The average annual Cost of Revenue growth rates for Ergomed PLC have been -31% over the past three years , -23% over the past five years .